Request Deal Involvement
Haleon completed the acquisition of the remaining 12% stake in Tianjin TSKF Pharmaceutical for $222m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
UBS
legal advisors
A&O Shearman
or
Principals
bidder
HALEON
vendor
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
target
TIANJIN TSKF PHARMACEUTICAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite